UPCOMING SESSIONS in ET
Fri, Nov 20, 2026
6:00 – 7:00 AM Bangkok
Sadness, Anger and Fear: Coping With the Emotions of Illness Hamide Eygoren Register
UPCOMING SESSIONS in ET
Fri, Nov 20, 2026 · 6:00 – 7:00 AM Bangkok
Sadness, Anger and Fear: Coping With the Emotions of Illness
Hamide Eygoren
Register
View all sessions

Amyloidosis Therapeutics Market Size, Share and Trends 2025 to 2034

The global amyloidosis therapeutics market size is calculated at USD 3.18 billion in 2025 and is forecasted to reach around USD 6.45 billion by 2034, accelerating at a CAGR of 8.18% from 2025 to 2034. The North America market size surpassed USD 1.38 billion in 2024 and is expanding at a CAGR of 8.28% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

Amyloidosis Therapeutics Market Key Takeaways

  • North America dominated the global market with the highest share of 47% in 2024.
  • Asia Pacific is estimated to expand at the fastest CAGR in the market between 2025 and 2034.
  • By treatment, the chemotherapy segment held the largest market share in 2024.
  • By treatment, the transplantation segment is anticipated to grow at a remarkable CAGR between 2025 and 2034.
  • By end user, the hospitals and clinics segment dominated the market with the largest share in 2024
  • By end user, the home care settings segment is anticipated to show fastest growth during the predicted timeframe